Clinical trials: sponsored by Oslo University Hospital
Infertility (IVF Patients)
Pilot Study of Discarded Blastocysts
The goal of this observational study is to determine multiomics patterns related to global embryo quality to help overcome the limitations of conventional embryo quality assessment.
- Trial name
- DECODE (NCT07429097)
- Testing
- Multiomics analysis
- Where
- Norway
- Volunteers
- 150 people
- Sponsor
- Igenomix
Malignant Melanoma
Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
This study, with 20 patients participating, will examine the safety and tolerability for the ipilimumab/UV1 combination in patients with unresectable or metastatic malignant melanoma.
- Trial name
- NCT02275416
- Testing
- Ipilimumab, UV1 vaccine, GM-CSF
- Where
- Norway
- Volunteers
- 12 people
- Sponsor
- Ultimovacs ASA
Non-small Cell Lung Cancer
A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.
In this study, up to 21 patients with lung cancer will receive UV1 (a therapeutic synthetic peptide vaccine) at different dose levels. The safety and tolerability of UV1 as well as immunological response will be assessed.
- Trial name
- UV1-hTERT2012L (NCT01789099)
- Testing
- UV1 synthetic peptide vaccine and GM-CSF
- Where
- Norway
- Volunteers
- 18 people
- Sponsor
- Ultimovacs ASA
Fluid and Electrolyte Imbalance, Overhydration
Contributing Factors to Local Bioimpedance Spectroscopy
This is an exploratory interventional study. The aim of the investigation is to identify and quantify contributing factors to local bioimpedance spectroscopy (BIS) measured by a wearable sensor patch, particularly the effect of…
- Conditions
- Fluid and Electrolyte Imbalance, Overhydration, Edema
- Trial name
- COBI (NCT06003205)
- Testing
- Wearable bioimpedance sensor
- Where
- Norway
- Volunteers
- 11 people, healthy volunteers welcome
- Sponsor
- Mode Sensors AS
Overhydration, Kidney Failure
Detecting Fluid Accumulation With a Wearable Bioimpedance Sensor
The investigation is a prospective cohort study, where two patient groups will be monitored by a wearable bioimpedance sensor during their scheduled treatment.
- Conditions
- Overhydration, Kidney Failure, Edema
- Trial name
- DELOS (NCT06053710)
- Testing
- Wearable bioimpedance sensor
- Where
- 2 sites in Norway
- Volunteers
- 24 people
- Sponsor
- Mode Sensors AS
Dehydration
Testing of an Electronic Patch During Mild Dehydration
The purpose of this study is to investigate the ability of a wearable bioimpedance sensor to detect mild dehydration in healthy volunteers following the administration of Furosemide.
- Trial name
- NCT05129358
- Testing
- Dehydration, Rehydration
- Where
- Norway
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Mode Sensors AS
Colonoscopy, Adenoma Colon
COLO-SW-1 Pivotal Clinical Investigation
The Clinical Investigation is a summative usability study and a 'first-in-patient'-study of the independent medical device software (MDSW) utilizing artificial intelligence.
- Trial name
- NCT05519098
- Testing
- COLO-SW-1
- Where
- 2 sites in Norway, Sweden
- Volunteers
- 34 people
- Sponsor
- Augere Medical AS
Autism Spectrum Disorder
Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Adults With Autism Spectrum Disorder
Oxytocin (OT) is a small, naturally occurring peptide currently in clinical use to stimulate lactation in breastfeeding women. The intranasal administration of OT has recently attracted attention as a potential novel treatment in…
- Trial name
- NCT02414503
- Testing
- 8IU intranasal oxytocin, 24IU intranasal oxytocin, OptiNose Breath Powered Bi
- Where
- Norway
- Volunteers
- 17 people
- Sponsor
- OptiNose AS
Brain Injuries, Intracranial Hypertension
Development and Evaluation of the ICP Waveform Tracing Capabilities and Safety of HS-1000 Device
Invasive intracranial pressure (ICP) monitoring, using modalities such as parenchymal pressure transducer or external ventricular drain (EVD), provides an ICP waveform that encapsulates valuable diagnostic and monitoring clinical…
- Trial name
- NCT02772471
- Testing
- HS-1000
- Where
- Norway
- Volunteers
- 40 people
- Sponsor
- HeadSense Medical
Cancer With Transdermal Accessible Tumour
Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour
The study will evaluate the safety profile for LTX-315 a lytic-peptide that has shown effect in animal models to kill cancer tumours when injected directly in to the tumour.
- Trial name
- NCT01058616
- Testing
- LTX-315 (Oncopore™)
- Where
- 2 sites in Norway, Sweden
- Volunteers
- 14 people
- Sponsor
- Lytix Biopharma AS